
    
      To test the hypothesis that the implantation of adipose-derived autologous cells derived from
      adipose tissue (hASCs) combined with coronary artery bypass grafting in patients with
      coronary artery disease is safe and well tolerated, besides being able to promote regional
      perfusion increase in the injected segments.
    
  